Canadian Cannabis LPs Continue To Plummet In April

Image source

The 5 largest licensed producers (LPs), as tracked in our munKNEE Canadian Cannabis LPs Index, are ranked below, in descending order, as to their:

  • stock performances as of April 20th (i.e. MTD) and year-to-date (YTD),
  • likelihood of Financial Distress within the next 2 years (according to data from macroaxis.com),
  • average Wall Street analyst 12-month Price Targets (from SeekingAlpha.com),
  • extent of Short Interest (the number of shorted shares divided by the number of shares outstanding),
  • percentage of Insider Ownership (directors and senior officers or other beneficial holders with 10% or more of the common shares),
  • percentage of Institutional Ownership, and
  • current market capitalizations.
  1. Cronos (CRON): DOWN 5.7% MTD; Now DOWN 27.4% YTD
    • 18 analysts:
      • have an average 12-month price target representing a 56% increase from its current price and
      • have a consensus BUY rating.
    • In addition, CRON has:
      • only a 2% chance of Financial Distress within 2 years,
      • 3.7% Short Interest,
      • 5.4% Insider Ownership,
      • 13.1% Institutional Ownership, and
      • $695M in Market Capitalization.
    • Altria Group (MO) has a 45% stake in CRON
  2. Tilray (TLRY): DOWN 8.3% MTD; Now DOWN 13.1% YTD
    • 22 analysts:
      • have an average 12-month price target representing a 87% increase from its current price and
      • have a consensus BUY rating.
    • In addition, TLRY has:
      • 68% chance of Financial Distress within 2 years,
      • 9.0% Short Interest,
      • 1.3% Insider Ownership,
      • 11.4% Institutional Ownership and
      • $1,450B in Market Capitalization.
    • Anheuser-Busch (BUD) has a $100 million joint venture with TLRY.
  3. Aurora (ACB): DOWN 12.9% MTD; Now DOWN 31.5% YTD
    • 14 analysts:
      • have an average 12-month price target representing a 167% increase from its current price and
      • have a consensus HOLD rating.
    • In addition, ACB has:
      • 78% chance of Financial Distress within 2 years,
      • 8.7% Short Interest,
      • 0.12% Insider Ownership,
      • 21.8% Institutional Ownership, and
      • $212M in Market Capitalization.
    • received a Nasdaq notice on March 27th that the company is no longer in compliance with the minimum bid price requirement as the price has been below $1.00 for a period of 30 consecutive business days and has been granted a period of 180 calendar days or until September 20, 2023 to regain compliance with the minimum bid price requirement.
  4. OrganiGram (OGI): DOWN 18.8%; Now DOWN 33.3% YTD
    • 15 analysts:
      • have an average 12-month price target representing a 152% increase from its current price and
      • have a consensus BUY rating.
    • In addition, OGI has:
      • 49% chance of Financial Distress within 2 years,
      • 2.1% Short Interest,
      • 0.09% Insider Ownership,
      • 11.3% Institutional Ownership. and
      • $163 in Market Capitalization.
    • British American Tobacco (BTI) has invested C$221M in a product development partnership with OGI
  5. Canopy Growth (CGC): DOWN 22.9% MTD; Now DOWN 40.5% YTD
    • 23 analysts:
      • have an average 12-month price target representing a 90% increase from its current price and
      • have a consensus SELL rating.
    • In addition, CGC has:
      • 53% chance of Financial Distress within 2 years,
      • 16.1% Short Interest,
      • 0.08% Insider Ownership,
      • 13.5% Institutional Ownership, and
      • $704M Market Capitalization.
    • Constellation Brands (STZ) has a 39% stake in CGC.

Summary

The munKNEE Canadian Cannabis LPs Index is DOWN 12.3% MTD and are now DOWN 27.4% YTD. The average 12-month price target represents a 91.7% increase from its current price. In comparison, the 7 constituents in the munKNEE American Cannabis MSOs Index is only DOWN 2.8% MTD and is now DOWN 22.3% YTD.


More By This Author:

These 44 Gold Analysts Provide Specific Forecast Dates
ETFs Outperforming The S&P 500, On Average
These 10 Gold And Silver Juniors Have Parabolic Potential

Disclosure: None

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.